Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction
暂无分享,去创建一个
J. Daubert | L. Lund | E. Donal | G. Savarese | C. Linde | C. Hage | U. Löfström
[1] J. Daubert,et al. Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) study. , 2019, International journal of cardiology.
[2] L. Lund,et al. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction. , 2018, Journal of cardiac failure.
[3] Roland A Matsouaka,et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. , 2017, Journal of the American College of Cardiology.
[4] Akshay S. Desai,et al. Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial. , 2017, JACC. Heart failure.
[5] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[6] L. Lund,et al. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study , 2015, European journal of heart failure.
[7] J. Daubert,et al. Association between cardiovascular vs. non‐cardiovascular co‐morbidities and outcomes in heart failure with preserved ejection fraction , 2014, European journal of heart failure.
[8] J. Daubert,et al. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study. , 2014, Archives of cardiovascular diseases.
[9] J. Daubert,et al. Rationale and design of the Karolinska‐Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction , 2009, European journal of heart failure.
[10] Serguei V. S. Pakhomov,et al. Systolic and diastolic heart failure in the community. , 2006, JAMA.
[11] Peter C Austin,et al. Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.
[12] V. Roger,et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.
[13] K. Swedberg,et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. , 2004, European heart journal.
[14] M. J. Lenzena,et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey , 2004 .
[15] T. Rector. Patients' self-assessment of their congestive heart failure : Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire , 1987 .
[16] W. Kannel,et al. The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.